"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

Colossal, values the Dallas-based startup at a staggering $10.2 billion. Besides making it the first startup founded in Texas to be valued at eleven figures, the new funding round will bolster ...

UK ministers are pressing ahead with legislation to adopt gene editing technology despite warnings from Brussels that it ...

Genetic engineering startup Colossal announced Wednesday it had reached a $10 billion valuation, the first startup in Texas ...

New breakthroughs in gene editing mean that cures for genetic diseases such as cystic fibrosis could be developed in the near ...

The UK’s plans to adopt the latest gene editing technology face delays over fears they will clash with EU law if Downing ...

Influential inventions often combine existing tools in new ways. The iPhone, for instance, amalgamated the telephone, web ...

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

Influential inventions often combine existing tools in new ways. The iPhone, for instance, amalgamated the telephone, web ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Merging Gene Editing and Regulation In a new paper in Nature Communications, researchers in the Center for Precision Engineering for Health (CPE4H) at the University of Pennsylvania School of ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.